Oral Composition

JP7755840B2Active Publication Date: 2025-10-17TOYO SHINYAKU KK
View PDF 13 Cites 0 Cited by

Patent Information

Application Number
JP2021091916
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-05-31
Publication Date
2025-10-17
Estimated Expiration
2041-05-31

AI Technical Summary

Technical Problem

Conventional oral compositions are inadequate in suppressing the expression of SREBF1 or promoting the expression of PPARα, HO-1, or NOS3, failing to effectively manage cholesterol and triglyceride levels, improve brain function, alleviate depressive states, enhance stress resistance, improve blood flow, or address erectile dysfunction.

Method used

An oral composition containing gallic acid and a combination of pomegranate, shilajit, hibiscus, mastic, and goldenrod or mango, with specific mass percentages and ratios, to inhibit or promote the expression of these proteins, thereby addressing the mentioned health issues.

Benefits of technology

The composition effectively suppresses or promotes the expression of SREBF1, PPARα, HO-1, and NOS3, leading to improved cholesterol and triglyceride management, enhanced brain function, reduced depressive states, increased stress resistance, improved blood flow, and alleviated erectile dysfunction.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007755840000001
    Figure 0007755840000001
  • Figure 0007755840000002
    Figure 0007755840000002
  • Figure 0007755840000003
    Figure 0007755840000003
Patent Text Reader

Abstract

To provide an oral composition that inhibits expression of SREBF1 or promotes expression of PPARα, HO-1 or NOS3 and thus may contribute to inhibiting increase or promoting decrease of neutral fat or cholesterol, improving brain functions, reducing and / or mitigating melancholic states such as depression due to stress, enhancing stress tolerance, improving the blood flow, relieving physical fatigue, or remedying erectile dysfunction.SOLUTION: The oral composition comprises gallic acid, and further comprises at least one selected from pomegranate, Shilajit, hibiscus, mastic, lonicerae flos and mango.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Medical health food

    JP2002238496A

  • Nutrition supplement of plant nutrient

    JP2004035550A

  • Medicine for treating or preventing angiofibrosis

    JP2007126480A

  • Mango extract

    JP2009215235A

  • A composition effective in preventing or slowing the progression of prostate cancer.

    JP2011529465A